Don't Expect to Add the Antiarrhythmic Bretylium to Crash Carts

The revival of bretylium will raise questions about antiarrhythmics for advanced cardiovascular life support (ACLS).

Bretylium was once a crash cart staple. But it was taken off the market in the late 1990s due to supply issues...and ACLS algorithms removed it, noting other meds work as well and are safer.

Now bretylium is back on the market. The manufacturer will suggest it's an option when amiodarone or lidocaine doesn't work or can't be used.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals